Molecular mechanisms of bile duct development
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The mammalian biliary system, consisting of the intrahepatic and extrahepatic bile ducts, is responsible for transporting bile from the liver to the intestine. Bile duct dysfunction, as is seen in some congenital biliary diseases such as Alagille syndrome and biliary atresia, can lead to the accumulation of bile in the liver, preventing the excretion of detoxification products and ultimately leading to liver damage. Bile duct formation requires coordinated cell-cell interactions, resulting in the regulation of cell differentiation and morphogenesis. Multiple signaling molecules and transcription factors have been identified as important regulators of bile duct development. This review summarizes recent progress in the field. Insights gained from studies of the molecular mechanisms of bile duct development have the potential to reveal novel mechanisms of differentiation and morphogenesis in addition to potential targets for therapy of bile duct disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The initiation of liver development is dependent on Foxa transcription factors
Lee, C. S., Friedman, J. R., Fulmer, J. T., & Kaestner, K. H. (2005) · Nature · doi:10.1038/nature03649 · Cited by 581 · cited 4×
“Liver-specific ablation of Foxa1 and Foxa2 causes bile duct hyperplasia and fibrosis due to the upregulation of IL-6, a proliferative signal for cholangiocytes (Li et al., 2009).”
BackgroundInfluentialMutations in PRKCSH cause isolated autosomal dominant polycystic liver disease
Li, A., Davila, S., Furu, L., Qian, Q., Tian, X., Kamath, P. S., King, B. F., Torres, V. E., & Somlo, S. (2003) · The American Journal of Human Genetics · doi:10.1086/368295 · Cited by 193 · cited 1×
“Another kind of PLD, called autosomal dominant polycystic liver disease (ADPLD), is not associated with any renal diseases and is associated with mutations in the PRKCSH and SEC63 genes (Davila et al., 2004; Drenth et al., 2003; Li et al., 2003).”
BackgroundSuzuki, A., Sekiya, S., Büscher, D., Izpisúa Belmonte, J. C., & Taniguchi, H. (2008) · Development · doi:10.1242/dev.016634 · Cited by 136 · cited 16×
“Expression of Foxa1 is upregulated in HNF6 null livers, probably due to the upregulation of TGFβ signaling (Plumb-Rudewiez et al., 2004).”
BackgroundInfluentialFoxa1 and Foxa2 regulate bile duct development in mice
Li, Z., White, P., Tuteja, G., Rubins, N., Sackett, S., & Kaestner, K. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38201 · Cited by 131 · cited 3×
“Liver-specific ablation of Foxa1 and Foxa2 causes bile duct hyperplasia and fibrosis due to the upregulation of IL-6, a proliferative signal for cholangiocytes (Li et al., 2009).”
BackgroundLüdtke, T. H. ‐., Christoffels, V. M., Petry, M., & Kispert, A. (2009) · Hepatology · doi:10.1002/hep.22700 · Cited by 117 · cited 2×
“5, Tbx3-deficient livers showed a paucity of hepatocyte markers but instead exhibited expression of biliary markers (Ludtke et al., 2009).”
BackgroundSall4 regulates cell fate decision in fetal hepatic stem/progenitor cells
Oikawa, T., Kamiya, A., Kakinuma, S., Zeniya, M., Nishinakamura, R., Tajiri, H., & Nakauchi, H. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.11.018 · Cited by 108 · cited 2×
“(Oikawa et al., 2009) Tbx3 Inhibit biliary differentiation and promote hepatocyte differentiation.”
Background
Cited by
Therapeutic modulation of Notch signalling — are we there yet?
Andersson, E. R., & Lendahl, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4252 · Cited by 457
Cholangiocyte organoids can repair bile ducts after transplantation in the human liver
Sampaziotis, F., Muraro, D., Tysoe, O. C., Sawiak, S., Beach, T. E., Godfrey, E. M., Upponi, S. S., Brevini, T., Wesley, B. T., Garcia-Bernardo, J., et al. (2021) · Science · doi:10.1126/science.aaz6964 · Cited by 394
Generation of hepatobiliary organoids from human induced pluripotent stem cells
Wu, F., Wu, D., Ren, Y., Huang, Y., Feng, B., Zhao, N., Zhang, T., Chen, X., Chen, S., & Xu, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.028 · Cited by 261
Regional Differences in Human Biliary Tissues and Corresponding In Vitro–Derived Organoids
Rimland, C. A., Tilson, S. G., Morell, C. M., Tomaz, R. A., Lu, W., Adams, S. E., Georgakopoulos, N., Otaizo‐Carrasquero, F., Myers, T. G., Ferdinand, J. R., et al. (2021) · Hepatology · doi:10.1002/hep.31252 · Cited by 110
“Indeed, the CBD, GBD, and PancD are derived from a common pancreatobiliary progenitor,(3) whereas IHBDs are derived from bipotent hepatoblasts, which give rise to hepatocytes and intrahepatic cholangiocytes.(3) This embryonic origin could facilitate transdifferentiation or dedifferentiation/ differentiation of IHBD or…”
InfluentialRoos, F. J. M., Wu, H., Willemse, J., Lieshout, R., Albarinos, L. A. M., Kan, Y., Poley, J., Bruno, M. J., de Jonge, J., Bártfai, R., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.566 · Cited by 40
Metadata
- Authors
- Zong, Y., & Stanger, B. Z.
- Venue
- The International Journal of Biochemistry & Cell Biology
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 43
- Issue
- 2
- Pages
- 257-264
- ISSN
- 1357-2725 (ISSN-L)
- OpenAlex
- W2053189764
- Cited by
- 95
- References
- 6
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular mechanisms of bile duct development. https://app.cochat.ai/papers/10.1016/j.biocel.2010.06.020
- The paper
- Zong, Y., & Stanger, B. Z. (2011). Molecular mechanisms of bile duct development. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2010.06.020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.